Evaluation of the Reproducibility of the Automated Measurement of the Extent of ILD on Chest CT
Evaluation of the Reproducibility of the Automated Measurement of the Extent of Interstitial Lung Disease on Chest CT
Assistance Publique - Hôpitaux de Paris
150 participants
Jun 24, 2025
INTERVENTIONAL
Conditions
Summary
In interstitial lung disease (ILD), the extent of ILD on chest computed tomography (CT) is recognized as an important prognostic factor. Automated tools are now available to quantify ILD, but there is a lack of data on the reproducibility of this measurement and therefore its accuracy. Therefore, the purpose of this study is to evaluate the variability of automated ILD quantification on chest CT. Reproducibility will be assessed by repeating chest CT scans and using different tools to measure the extent of disease.
Eligibility
Inclusion Criteria6
- Age ≥ 18 years
- Known interstitial lung disease as part of idiopathic pulmonary fibrosis or connective tissue disease
- Followed in one of the participating hospitals
- Requiring a chest CT as part of a scheduled assessment
- Affiliated to a French national social security
- Informed consent
Exclusion Criteria5
- Acute exacerbation of ILD
- Pregnancy
- Inability to hold an apnea for 10 seconds
- Patients in the exclusion period after a previous research
- Need for additional procubitus or expiratory images
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Repeated chest CT for automated ILD quantification
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06743022